Guidance and protocol for the serological diagnosis of human infection with Bordetella pertussis
External quality assessment scheme for Bordetella pertussis serology 2016
This external quality assessment (EQA) to assess the ability of national reference laboratories from EU/EEA Member States to correctly perform laboratory serodiagnostic tests for pertussis was a collaborative study organised from February to April 2016.
External quality assurance scheme for Bordetella identification and B. pertussis typing 2013
This report presents the results of the first external quality assurance (EQA) scheme for Bordetella identification and typing funded by the European Centre for Disease Prevention and Control (ECDC).
External quality assurance scheme for Bordetella pertussis serology 2013
This report presents the results of an external quality assurance (EQA) scheme for Bordetella pertussis serology which was carried out during the summer of 2013.
Expert consultation on pertussis
This report presents the outcomes of a technical workshop, organised by ECDC, to seek a consensus on a common strategy to reduce the public health burden caused by pertussis in the EU/EEA countries.
Rapid Risk Assessment: Shortage of acellular pertussis-containing vaccines and impact on immunisation programmes in the EU/EEA, 13 October 2015
Early in 2015, a shortage of acellular pertussis-containing vaccines was brought to the attention of ECDC. This risk assessment provides a detailed list of mitigation options available to Member States.
Expert opinion on childhood immunisation schedule: Diphtheria-tetanus-pertussis (DTP) vaccination
Current childhood vaccination schedules are the result of historical tradition, compliance with provision of health services and national vaccine registration. They have been designed on the basis of different needs related to how the healthcare system – but also the education system – is organised at national level.
Pertussis - Annual Epidemiological Report for 2016
In 2016, 48 446 cases of pertussis were reported in 30 EU/EEA countries.
Accelerating Control of Pertussis in England and WalesArchived
Despite a reduction in pertussis among younger children and infants, rates of pertussis-related sickness and death remain high compared with rates for other vaccine-preventable diseases in England and Wales.
External quality assessment (EQA) scheme on PCR for Bordetella pertussis, 2012 on behalf of the EUpert-labnet network
ECDC is publishing the first external quality assurance scheme (EQA) for Bordetalla pertusis PCR, participated by 21-one laboratories from 21 European Union/European Economic Area countries.